NASDAQ:ALHC - Nasdaq - US01625V1044 - Common Stock - Currency: USD
15.69
+2.22 (+16.48%)
The current stock price of ALHC is 15.69 USD. In the past month the price increased by 3.22%. In the past year, price increased by 178.19%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UNH | UNITEDHEALTH GROUP INC | 17.01 | 437.10B | ||
ELV | ELEVANCE HEALTH INC | 12.04 | 92.04B | ||
HUM | HUMANA INC | 16.7 | 32.62B | ||
CNC | CENTENE CORP | 8.19 | 28.84B | ||
MOH | MOLINA HEALTHCARE INC | 13.29 | 16.71B | ||
HQY | HEALTHEQUITY INC | 35.75 | 9.51B | ||
CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.99B | ||
PGNY | PROGYNY INC | 25.9 | 1.92B | ||
NEUE | NEUEHEALTH INC | 5.55 | 60.77M |
Alignment Healthcare, Inc. operates as a holding company. The company is headquartered in Orange, California and currently employs 1,536 full-time employees. The company went IPO on 2021-03-26. The firm's operations consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. Its consumer brand name, Alignment Health, offers more than 50 Medicare Advantage plans that serve 53 counties across six states. The company partners with nationally recognized and local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, Alignment's Virtual Application (AVA). AVA is designed specifically for senior care and provides end-to-end coordination of the healthcare ecosystem. AVA's suite of tools and services is built within a unified data architecture. Medicare Advantage plans are direct-to-consumer and provide a single point of care delivery for hospital insurance benefits, outpatient services and often prescription drug coverage.
ALIGNMENT HEALTHCARE INC
1100 W. Town And Country Road, Suite 1600
Orange CALIFORNIA 92868 US
CEO: John Kao
Employees: 1536
Company Website: https://www.alignmenthealth.com/
Investor Relations: http://ir.alignmenthealth.com/
Phone: 18443102247
The current stock price of ALHC is 15.69 USD. The price increased by 16.48% in the last trading session.
The exchange symbol of ALIGNMENT HEALTHCARE INC is ALHC and it is listed on the Nasdaq exchange.
ALHC stock is listed on the Nasdaq exchange.
19 analysts have analysed ALHC and the average price target is 14.28 USD. This implies a price decrease of -8.99% is expected in the next year compared to the current price of 15.69. Check the ALIGNMENT HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALIGNMENT HEALTHCARE INC (ALHC) has a market capitalization of 3.01B USD. This makes ALHC a Mid Cap stock.
ALIGNMENT HEALTHCARE INC (ALHC) currently has 1536 employees.
ALIGNMENT HEALTHCARE INC (ALHC) has a support level at 12.21 and a resistance level at 15.7. Check the full technical report for a detailed analysis of ALHC support and resistance levels.
The Revenue of ALIGNMENT HEALTHCARE INC (ALHC) is expected to grow by 29.89% in the next year. Check the estimates tab for more information on the ALHC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALHC does not pay a dividend.
ALIGNMENT HEALTHCARE INC (ALHC) will report earnings on 2025-04-30, after the market close.
ALIGNMENT HEALTHCARE INC (ALHC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.68).
The outstanding short interest for ALIGNMENT HEALTHCARE INC (ALHC) is 7.4% of its float. Check the ownership tab for more information on the ALHC short interest.
ChartMill assigns a technical rating of 10 / 10 to ALHC. When comparing the yearly performance of all stocks, ALHC is one of the better performing stocks in the market, outperforming 98.03% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to ALHC. ALHC may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ALHC reported a non-GAAP Earnings per Share(EPS) of -0.68. The EPS increased by 12.82% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -16.37% | ||
ROE | -128.23% | ||
Debt/Equity | 3.22 |
ChartMill assigns a Buy % Consensus number of 83% to ALHC. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 24.25% and a revenue growth 29.89% for ALHC